SMART-HF guided workflow improved PAD control in adults with heart failure and implanted sensors.
This retrospective cohort study examined the impact of SMART-HF, a structured pulmonary artery diastolic pressure-guided workflow, in a community setting. The population consisted of adults with heart failure and an implanted pulmonary artery pressure sensor. The sample included 37 patients, of whom 36 had paired 90-day windows and 29 had paired 6-month windows for analysis.
Primary analysis focused on pulmonary artery diastolic pressure (PAD) control. Mean PAD at 90 days decreased from 18.3 +/- 7.0 to 16.1 +/- 6.3 mmHg, representing a mean reduction of -2.2 mmHg (P < 0.001). At 6 months, mean PAD decreased from 18.8 +/- 6.8 to 15.5 +/- 5.8 mmHg, a mean reduction of -3.3 mmHg (P < 0.001). Secondary outcomes included 90-Day Target HMPI achievement, reached in 26/36 patients (72.2%), and 6-Month Delta HMPI achievement, reached in 19/29 patients (65.5%; 95% CI 45.7-82.1).
Exploratory subgroup analyses assessed patients with baseline PAD >20 mmHg. At 90 days, mean PAD change was -2.9 +/- 3.6 mmHg (n=19; P = 0.002). At 6 months, mean PAD change was -4.9 +/- 4.9 mmHg (n=15; P = 0.002). Safety, tolerability, adverse events, discontinuations, and serious adverse events were not reported.
Limitations include the retrospective design and small sample size. The study suggests SMART-HF was associated with improved ambulatory pulmonary artery diastolic pressure control. Further evaluation is warranted, particularly for patients with elevated baseline pulmonary artery diastolic pressure.